Berlin Startup Cellbricks Races to 3D-Print Human Livers and Kidneys

A Berlin-based startup called Cellbricks is working on a groundbreaking way to create human organs. Using 3D printing and a patient's own cells, the company plans to build new livers and kidneys without relying on donors. This week, it announced a major funding boost to push the technology forward. Cellbricks Therapeutics launched with a bold mission: manufacturing fully functional human organs through 3D printing. Instead of waiting for organ donors, the process uses cells taken directly from the patient. This approach aims to reduce rejection risks and speed up transplant availability.

The company has now secured €10 million in total funding. A €7 million seed round, led by Silicon Roundabout Ventures, forms part of this sum. Additional non-dilutive funds are still under negotiation, further strengthening the startup's financial position. Co-CEO Alexander Leutner leads the team behind this ambitious project. Their immediate focus is on developing replacement livers and kidneys—two of the most in-demand organs for transplants. If successful, the technology could transform how patients receive life-saving treatments.

With fresh funding in place, Cellbricks will accelerate its research into 3D-printed organs. The company's method, using a patient's own cells, could eventually eliminate long transplant waiting lists. For now, the team is working to turn their vision into a reality.